, in the rat UT-A1 sequence was the first step in understanding the mechanism of vasopressin action on the phosphorylation-dependent modulation of urea transport. To investigate the significance of multisite phosphorylation of UT-A1 in response to elevated cAMP, we used highly specific and sensitive phosphosite antibodies to Ser 486 and Ser 499 to determine cAMP action at each phosphorylation site. We found that phosphorylation at both sites was rapid and sustained. Furthermore, the rate of phosphorylation of the two sites was similar in both mIMCD3 cells and rat inner medullary tissue. UT-A1 localized to the apical membrane in response to vasopressin was phosphorylated at Ser 486 and Ser 499 . We confirmed that elevated cAMP resulted in increased phosphorylation of both sites by PKA but not through the vasopressin-sensitive exchange protein activated by cAMP pathway. These results elucidate the multisite phosphorylation of UT-A1 in response to cAMP, thus providing the beginning of understanding the intracellular factors underlying vasopressin stimulation of urea transport in the IMCD. vasopressin; urea transport; adenosine 3=,5=-cyclic monophosphate; urea transporter-A1
vasopressin; urea transport; adenosine 3=,5=-cyclic monophosphate; urea transporter-A1 VASOPRESSIN REGULATION of urea transporter (UT)-A1 is a vital part of producing concentrated urine (12) . We and others have shown that elevated intracellular cAMP, elicited by vasopressin, increased urea permeability and the abundance of phosphorylated (p)UT-A1 (20) , suggesting that phosphorylation regulates urea transport. This hypothesis ultimately led to the identification of Ser 486 in UT-A1 by phosphoproteomic analysis as a potential vasopressin-stimulated phosphorylation site (10) . Our laboratory also identified Ser 486 as a potential vasopressin-stimulated phosphorylation site and identified Ser 499 as a second potential phosphorylation site (3) . Using site-directed mutagenesis and transient transfection in heterologous expression systems, we showed that both Ser 486 and Ser 499 were phosphorylated in a cAMP-dependent manner (3) .
The identification of multiple vasopressin-sensitive phosphorylation sites in UT-A1 is key to the regulation of transporter function. Multisite protein phosphorylation can provide a precise tool for dynamic regulation of downstream signaling. Furthermore, different phosphorylation profiles of a single protein might be linked to different cellular functions. A study (19) of another protein in the inner medullary collecting duct (IMCD), a water channel, aquaporin-2 (AQP2), also identified multiple vasopressin-sensitive phosphorylation sites in its protein sequence. Investigations have shown that each identified residue has a unique contribution to the localization of AQP2 and subsequent water permeability (19) . Our initial investigations found that mutation of both Ser 486 and Ser 499 to alanines, but not either one alone, eliminated vasopressin stimulation of UT-A1 apical plasma membrane accumulation and urea transport, indicating that at least one of these serines must be phosphorylated to increase urea flux and UT-A1 accumulation in the apical plasma membrane (3) . On account of these findings and the importance of posttranslational modifications in regulating another IMCD membrane protein, AQP2, there is a need for further investigation into the physiological significance of the two cAMP-sensitive phosphorylation sites in UT-A1 and the role that these sites may have in the localization and regulation of the transporter.
In addition to modifying activity and subcellular localization, multisite phosphorylation of UT-A1 may be a mechanism for introducing control by different signaling pathways. The cellular response to vasopressin, mediated by cAMP, is generally thought to occur through PKA; however, cAMP may have several downstream targets. Previous work has shown that only 50% of forskolin-stimulated urea flux is inhibited by H-89, a PKA inhibitor (8) . This led to the investigation of PKA-independent pathways triggered by increased cAMP in the IMCD, such as those mediated by exchange protein activated by cAMP (Epac), a guanine nucleotide exchange factor for both Rap1 and Rap2 (7) . We discovered that stimulation of Epac increases urea transport, accumulation of UT-A1 at the plasma membrane, and UT-A1 phosphorylation (22) . Given its localization at the membrane of the renal epithelium (16), it is not surprising that Epac is involved in cAMP-mediated regulation of apical membrane processes, such as phosphorylation of UT-A1.
Thus far, a major difficulty in studying the cAMP-sensitive multisite phosphorylation of UT-A1 has been due to a lack of antibodies specific for the detection of phosphorylation at Ser 486 and Ser 499 . Our group (11) has previously characterized an antibody that specifically recognizes phosphorylation of UT-A1 at Ser 486 , and, in the present study, we developed a highly specific and sensitive phosphosite antibody to Ser
499
. By combining these unique tools, we will elucidate the need for two vasopressin-sensitive phosphorylation sites for the regulation of UT-A1.
METHODS
Animals. All animal protocols were approved by the Institutional Animal Care and Use Committee of Emory University. Male SpragueDawley rats (Charles River Laboratories, Wilmington, MA), weighing 100 -150 g, received free access to water and standard rat chow (Test diet 5001, Purina) containing 23% protein.
Cells. mIMCD3 cells (American Type Culture Collection) were grown in equal mixtures of DMEM and Ham's F-12 medium supplemented with 10% FBS, 100 U/ml penicillin, and 100 g/ml streptomycin at 37°C in a humidified atmosphere of 95% air-5% CO 2. Cells were grown on six-well plates. At 60% confluence, cells were transfected with UT-A1 (wild type), UT-A1-S499A, or vehicle using Effectene (Qiagen, Hilden, Germany) according to the manufacturer's instructions. Maximal protein expression occurred after 36 h.
Other experiments used a mIMCD3 cell line that stably expressed UT-A1 previously generated in our laboratory (11); mIMCD3 cells were grown under the same conditions as described above.
Tissue and cell sample preparation. Previously generated stable mIMCD3-UT-A1 cells and/or cells transfected with UT-A1 (wild type) UT-A1-S486A, or UT-A1-S499A were grown to confluence in six-well plates. After the described treatments, cells were scraped from the surface and solubilized by boiling in Laemmli buffer.
Kidneys were removed, and the inner medulla was collected. For ex vivo treatments, inner medullary tissue was cut into small pieces (1 ϫ 1 ϫ 1 mm) and incubated in DMEM with vehicle or the designated treatment(s) for the indicated times at 37°C. For Western blot analysis, tissues were homogenized in ice-cold isolation buffer [10 mM triethanolamine, 250 mM sucrose (pH 7.6), 1 g/ml leupeptin, and 2 mg/ml PMSF], and SDS was then added to a final concentration of 1%. Samples were then solubilized by boiling in Laemmli buffer.
Metabolic labeling with [ 32 P]orthophosphate. Metabolic labeling with [ 32 P]orthophosphate was performed with mIMCD3-UT-A1 cells and inner medullary rat tissue as previously described (2, 3) . Briefly, confluent cells or inner medulla pieces were incubated in phosphatefree DMEM containing 0.2 mCi/ml [ 32 P]orthophosphate. After the 3-h labeling period, cells or tissues were incubated for a further 30 min with either vehicle or the designated treatment(s). Lysates were prepared, and UT-A1 was immunoprecipitated. Precipitated proteins were separated by SDS-PAGE, and radiolabeled UT-A1 was determined by autoradiography of the dried gel.
Primary antibodies. Three primary antibodies were used in these experiments: 1) a polyclonal antibody to the COOH terminal of UT-A1 to assess total UT-A1 (14), 2) a phospho-specific antibody to UT-A1 phosphorylated at Ser 486 (11) , and 3) a new phospho-specific antibody to UT-A1 phosphorylated at Ser 499 . To acquire the 499 phospho-antibody, we commissioned PhosphoSolutions (Aurora, CO) to assist in the generation of the antibody. We designed an immunizing peptide prepared against our site of interest: SIRRRS(P)KVF-GK[C]-NH 2. Using this phosphopeptide, a rabbit was immunized, and serum was collected 8 wk later. To isolate the 499 phospho-specific antibody, the IgG fraction was collected from the serum and applied to a phospho-peptide affinity column. This column bound both the 499 phospho-specific antibody and a pan-specific antibody. These two antibodies were eluted from the phosphopeptide affinity column and then applied to a dephosphopeptide affinity column. This column bound the pan-specific antibody, allowing the 499 phospho-specific antibody to be collected in the flowthrough. The 499 phospho-specific antibody was first characterized at PhosphoSolutions by ELISA before further characterization in our laboratory, as described in RESULTS. Western blot analysis. Proteins (20 g/lane) were size separated by SDS-PAGE on 10% gels and then electroblotted to polyvinylidene difluoride membranes (Immobilon, Millipore, Bedford, MA). After being blocked with 5% nonfat dry milk for 1 h, blots were incubated with primary antibody overnight at 4°C. Blots were washed three times in Tris-buffered saline with 0.5% Tween 20 and then incubated for 2 h with Alexa fluor 680-linked anti-rabbit IgG (Molecular Probes, Eugene, OR). Bound secondary antibody was visualized using infrared detection with the LI-COR Odyssey protein analysis system (Lincoln, NE), and densitometry of the desired band was collected. Blots were then stained with Coomassie, and densitometry of protein loading was determined by ImageJ. Densitometry values collected from the Coomassie staining were used to normalize Western blot data.
Immunohistochemistry. Kidneys from rats that had been injected in the interperitoneal cavity with saline or vasopressin 45 min before they were perfusion fixed with 4% paraformaldehyde were embedded in paraffin and sectioned into 4-m slices. Tissue slices were stained overnight with primary antibodies diluted in PBS (1:1,000 anti-COOH-terminal UT-A1, 1:100 Ser 486 -pUT-A1, and 1:200 Ser 499 -pUT-A1) and incubated for 2 h with Alexa fluor 488-linked goat anti-rabbit IgG (Invitrogen, Carlsbad, CA) for fluorescent confocal microscopy, as previously described (12) . Slices for confocal micrographs were also treated with the nuclear stain 4=,6-diamidino-2-phenylindole. Confocal microscopy was performed with a Zeiss LSM 510 META ZEN confocal microscope and LSM ZEN imaging software.
Statistics. Data are presented as means Ϯ SE; comparisons were made with either an unpaired t-test with Welch's correction or one-way ANOVA and Fisher's least-significant-difference posttest. P values of Ͻ0.05 were considered significant.
RESULTS

Phospho-specific antibody to Ser
499 in UT-A1. We generated an antibody that specifically detects UT-A1 phosphorylation at Ser 499 . Forskolin treatment of mIMCD3 cells transiently transfected with UT-A1 revealed a significant increase in UT-A1 phosphorylation at Ser 499 without a change in total protein abundance (Fig. 1A) . To determine specificity to Ser 499 , mIMCD3 cells were transfected with a UT-A1 construct where Ser 499 was changed to Ala 499 by site-directed mutagenesis. Although replacing the serine at site 499 did not affect expression or protein structure, phosphorylation at site 499 was undetectable with the Ser 499 -pUT-A1 antibody in the mutated construct (Fig. 1B) .
Elevated cAMP increases UT-A1 phosphorylation at Ser 486
and Ser 499 at similar rates. Using a mIMCD3 cell line that stably expresses UT-A1, the rate of cAMP-mediated phosphorylation at Ser 486 and Ser 499 was determined (Fig. 2) . Using Western blot analysis on samples treated with forskolin for increasing periods of time, we observed that phosphorylation at both Ser 486 and Ser 499 was increased within 1 min of forskolin treatment ( Fig. 2A) . Extending the time of forskolin treatment revealed that maximum phosphorylation of both sites was reached at 2 min and remained stable for the remaining 20 min of observation (Fig. 2B) . There was no variation in the rate of phosphorylation in response to increased cAMP between Ser 486 and Ser 499 . Generation of the Ser 499 -pUT-A1 antibody, in combination with the existing Ser medulla was increased with increasing periods of incubation with forskolin ( Fig. 3B ), similar to a previous report (23) in other models. UT-A1 phosphorylation at Ser 486 and Ser 499 were elevated in the inner medulla within 2 min and remained constant after 10 min of forskolin incubation (Fig. 3B) .
UT-A1 phosphorylation at Ser 486 and Ser 499 sites occur independently of one another. Multisite phosphorylation of a protein may depend on a hierarchical organization where phosphorylation of one site is subordinate to the phosphorylation of a separate site. Conversely, phosphorylation of multiple sites may occur in an independent manner. Using site-directed mutagenesis, we found that forskolin increased phosphorylation of the UT-A1 Ser 499 site in the absence of an active Ser 486 site (Fig. 4) . Furthermore, forskolin stimulated phosphorylation at Ser 486 despite rendering the Ser 499 site inactive (Fig. 4) . UT-A1 phosphorylated at Ser 486 and Ser 499 in response to vasopressin is localized to the apical membrane of the IMCD. Because a majority of cAMP in the IMCD is synthesized in response to vasopressin (15) , phosphorylation of UT-A1 at Ser 486 and Ser 499 is likely a downstream effect of this hormone. Inner medullary tissue from vasopressin-treated rats had increased phosphorylation of both glycoprotein forms of UT-A1 at these two cAMP-sensitive sites (Fig. 5) .
To assess the cellular location of UT-A1 after cAMPmediated phosphorylation in vivo, kidneys from vasopressintreated rats were examined histologically. Vasopressin increased total UT-A1 accumulation at the apical plasma membrane of the IMCD (Fig. 6) , supporting findings of a previous report (13) . These images show that UT-A1 phosphorylated at Ser 499 was predominately expressed at the apical plasma membrane (Fig. 6) . UT-A1 phosphorylated at Ser 486 was also found predominately at the apical plasma membrane (Fig. 6) , consistent with our previous findings (11) .
Phosphorylation of UT-A1 at Ser 486 and Ser 499 is mediated by PKA. The common kinase that amplifies cAMP signaling is PKA. Using mIMCD3-UT-A1 cells, we observed that inhibition of PKA by H-89 reduced total phosphorylation of UT-A1 (Fig. 7) . Forskolin-treated cells showed that the addition of H-89 not only inhibited phosphorylation of UT-A1 at both Ser 486 and Ser 499 but also damped basal phosphorylation at these sites as well (Fig. 7) . 486 and Ser 499 . Vasopressin also activates an Epac signaling pathway that has been proven to stimulate urea transport, UT-A1 phosphorylation, and UT-A1 accumulation in the plasma membrane of rat IMCDs (22) . Consistent with our previous study, total UT-A1 phosphorylation was significantly increased above basal levels when Epac was specifically stimulated pharmacologically with Sp-8-pCPT-2=-O-methyl-cAMPS in mIMCD3-UT-A1 cells (Fig. 8 ). There was no change in phosphorylation at either Ser 486 and Ser 499 after Epac stimulation in this cell line (Fig. 8 ).
Activation of the Epac pathway does not affect phosphorylation of UT-A1 at Ser
DISCUSSION
A current challenge in understanding how urine is concentrated is the absence of a detailed knowledge of how vasopressin signaling networks integrate and transmit signals to specific transport proteins in the inner medulla. Although phosphorylation is not the only regulatory system in the IMCD, it is intimately tied to many other intracellular systems that ultimately control water and urea movement across the cell membrane. Therefore, an important step in exploring responsiveness to vasopressin signaling is the identification and characterization of phosphorylation sites on the proteins that regulate water and urea reabsorption, AQP2 and UT-A1. Multisite phosphorylation can modulate the biological activity and subcellular location of target proteins like AQP2 and UT-A1 as well as determine the extent and duration of cellular response; thus, further clarification of the role of each phosphorylation site on these inner medullary transporters is needed.
A considerable amount of work has already justifiably focused on the vasopressin-sensitive phosphorylation sites of AQP2. This water channel has four vasopressin-sensitive phosphorylation sites: Ser 256 , Ser 261 , Ser 264 , and Ser 269 (1, 10) . Following identification of these sites, further work revealed that Ser 256 and Ser 261 are involved in AQP2 trafficking to the apical plasma membrane (9) and that elevated cAMP levels result in increased initial phosphorylation of AQP2 at Ser 256 followed by increased Ser 264 and Ser 269 phosphorylation and reduced Ser 261 phosphorylation (9, 18, 21) . These posttranslational modifications are key for the steady-state redistribution of AQP2 between vesicles and the apical plasma membrane by regulated exocytosis and endocytosis (19) . Due to these and many additional nuances of the multiple vasopressin-sensitive phosphorylation sites of AQP2, it is safe to conclude that each residue has a unique contribution to the localization and ultimately function of AQP2. This advanced body of work on AQP2 led us to investigate whether there were similar differ- comprised independent posttranslational events that were not hierarchical in the presence of elevated cAMP. Different phosphorylations could be linked to distinct protein functions or graded effects of a single function (6) . Our earlier work showed that phosphorylation of either Ser 486 and Ser 499 is sufficient for activation, whereas maximal urea permeability is achieved when both sites are phosphorylated (3) . In addition to demonstrating that Ser 486 and Ser 499 are distinct targets for phosphorylation, our data suggest that the two phosphorylation sites provide a possible feedback amplification mechanism to fully activate urea transport. Such a mechanism could result in a graded response and thus allow even low levels of vasopressin to transport measured urea across the IMCD. This is certainly plausible from a physiological standpoint and warrants further future investigation.
The present results also showed that UT-A1 phosphorylated at either Ser 486 or Ser 499 was localized to the apical membrane . Elevated vasopressin increases phosphorylation of UT-A1 at S486 and S499 in the rat inner medulla. Sprague Dawley rats were injected without (Ϫ) arginine vasopressin (AVP; saline) or with (ϩ) 5 nmol AVP 45 min before kidneys were removed and the inner medulla was collected and subsequently homogenized. The resulting lysates were subjected to Western blot analysis for the determination of vasopressin effects on total UT-A1, phosphorylation of UT-A1 at S486 (pUT-A1/ S486), and phosphorylation of UT-A1 at S499 (pUT-A1/S499). Representative blots are shown with the glycosylated forms of UT-A1 highlighted by brackets. Each lane represents the inner medullas from one animal. n ϭ 4. Fig. 6 . Phosphorylated UT-A1 is located at the apical surface of the inner medullary collecting duct. Sprague-Dawley rats were injected with either saline (sham treatment) or vasopressin (5 nmol) 45 min before kidneys were perfusion fixed and embedded in paraffin. Immunofluorescence was performed on 4-m sections, and the location of total UT-A1, UT-A1 phosphorylated at S486, and UT-A1 phosphorylated at S499 was determined by confocal microscopy. n ϭ 5. 
